Syndax Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Jun 23 | Sell€11,919 | Keith Goldan | Individual | 577 | €20.66 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,286 | 0.00368% |
Individual Insiders | 336,729 | 0.377% |
Institutions | 89,066,693 | 99.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,585,221 | €155.3m | -0.75% | 0.03% | |||
7,015,548 | €143.7m | 19.3% | no data | |||
5,660,000 | €115.9m | 57.2% | 9.22% | |||
5,016,224 | €102.7m | 39.3% | no data | |||
4,335,353 | €88.8m | 19.9% | no data | |||
4,222,222 | €86.5m | 65.2% | 1.3% | |||
3,950,000 | €80.9m | 40% | 3.24% | |||
3,383,244 | €69.3m | 30.3% | 6.05% | |||
2,834,499 | €58.1m | 23.2% | 0.13% | |||
2,737,520 | €56.1m | 151% | 0.01% | |||
2,101,911 | €43.0m | 248% | 0.1% | |||
1,875,000 | €38.4m | 0% | 0.98% | |||
1,749,000 | €35.8m | 36.2% | 0.52% | |||
1,544,216 | €31.6m | 4,430% | 0.36% | |||
1,535,055 | €31.4m | 12.8% | no data | |||
1,434,058 | €29.4m | 194% | no data | |||
1,334,531 | €27.3m | 0% | 0.01% | |||
1,175,000 | €24.1m | 0% | 1.38% | |||
1,121,358 | €23.0m | -6.3% | 0.01% | |||
1,094,494 | €22.4m | 0% | 6.6% | |||
1,075,786 | €22.0m | 14.2% | 1.75% | |||
1,025,000 | €21.0m | 0% | 8.81% | |||
1,021,032 | €20.9m | 325% | 0.06% | |||
951,607 | €19.5m | 394% | 0.01% | |||
942,642 | €19.3m | 114% | 0.02% |